Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
A health worker practitioner administers a coronavirus test in Brockton, Massachusetts, on Aug. 13. Photo: David L. Ryan/The Boston Globe via Getty Images
The Food and Drug Administration issued an emergency use authorization to Yale School of Public Health for its SalivaDirect COVID-19 diagnostic test on Saturday.
Why it matters: The test uses a new method of rapidly processing saliva samples when testing for the virus and "is yet another testing innovation game changer that will reduce the demand for scarce testing resources,” said Assistant Secretary for Health and COVID-19 Testing Coordinator Admiral Brett Giroir.
How it works: The test, deemed less expensive and less invasive than traditional methods, does not require specific swabs or collection devices to gather samples. Instead, a patient's saliva can be collected in any sterile container, which could cut down on the use of medical supplies the FDA says are in shortage.
- Samples are also collected under the observation of a health care professional, meaning the method could also lower the risk posed to workers who handle samples.
What they're saying: "Because this test does not rely on any proprietary equipment from Yale and can use a variety of commercially available testing components, it can be assembled and used in high-complexity labs throughout the country," the FDA said.
The big picture: This is the fifth test the FDA has allowed that uses saliva as a sample for testing.
- SalivaDirect is being further validated as a test for asymptomatic people through a program that tests players and staff from the NBA, YaleNews writes.